ALPHS — Pharmasimple SA Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -13.13% | ||
| Return on Equity | -24.55% | ||
| Operating Margin | -3.04% | ||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 11.34 | 19.07 | 16.8 | 28.23 | 45.53 | n/a | n/a | 46.25% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Pharmasimple SA is a Belgium-based company engaged in the Internet services industry. The Company operates the Website, through which sells pharmaceutical and cosmetics products. Its products portfolio encompasses drugs, food supplements, hygiene, face, body, hair, baby, man, solar, dietetic products, face accessories, anti-aging cream, cleansing cotton, eye contour, eye make-up remover, foaming gel, scrub, cleansing oil, cleansing milk, cleansing wipes, micellar lotion, makeup, mask, foam, oily skin, mixed skin, dry skins, serum, lip sticks, anti-stain care, anti-redness treatment , matifying care, young skin care tonic, and waxing bath sponges and brushes, among others.
Directors
- Last Annual
- December 31st, 2020
- Last Interim
- December 31st, 2020
- Incorporated
- April 27th, 2012
- Public Since
- November 17th, 2016
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Euronext - Paris
- Shares in Issue
- 152,947
- Address
- Houdeng-Goegnies Boulevard Millenium 11, BRUXELLES, 1000
- Web
- https://pharmasimple.com/
- Phone
- +32 64446656
- Auditors
- Deloitte Reviseurs d'Entreprises SC s.f.d. SCRL
Upcoming Events for ALPHS
Similar to ALPHS
Acteos SA
Euronext - Paris
Alten SA
Euronext - Paris
Atos SE
Euronext - Paris
Aubay SA
Euronext - Paris
Axway Software SA
Euronext - Paris
FAQ
As of Today at 18:17 UTC, shares in Pharmasimple SA are trading at €0.01. This share price information is delayed by 15 minutes.
Shares in Pharmasimple SA last closed at €0.01 and the price had moved by -100% over the past 365 days. In terms of relative price strength the Pharmasimple SA share price has underperformed the FTSE Global All Cap Index by -100% over the past year.
The overall consensus recommendation for Pharmasimple SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Pharmasimple SA does not currently pay a dividend.
Pharmasimple SA does not currently pay a dividend.
Pharmasimple SA does not currently pay a dividend.
To buy shares in Pharmasimple SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.01, shares in Pharmasimple SA had a market capitalisation of .
Here are the trading details for Pharmasimple SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALPHS
Based on an overall assessment of its quality, value and momentum Pharmasimple SA is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pharmasimple SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -99.76%.
As of the last closing price of €0.01, shares in Pharmasimple SA were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Pharmasimple SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Pharmasimple SA's directors